These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth. Chollet A; Mori G; Menendez C; Rodriguez F; Fabing I; Pasca MR; Madacki J; Korduláková J; Constant P; Quémard A; Bernardes-Génisson V; Lherbet C; Baltas M Eur J Med Chem; 2015 Aug; 101():218-35. PubMed ID: 26142487 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro biological evaluation of ring B abeo-sterols as novel inhibitors of Mycobacterium tuberculosis. Wei X; Rodríguez AD; Wang Y; Franzblau SG Bioorg Med Chem Lett; 2008 Oct; 18(20):5448-50. PubMed ID: 18818073 [TBL] [Abstract][Full Text] [Related]
11. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design. Cook BN; Bentzien J; White A; Nemoto PA; Wang J; Man CC; Soleymanzadeh F; Khine HH; Kashem MA; Kugler SZ; Wolak JP; Roth GP; De Lombaert S; Pullen SS; Takahashi H Bioorg Med Chem Lett; 2009 Feb; 19(3):773-7. PubMed ID: 19111460 [TBL] [Abstract][Full Text] [Related]
12. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives. Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154 [TBL] [Abstract][Full Text] [Related]
13. Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII Olaru AM; Vasilache V; Danac R; Mangalagiu II J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1291-1298. PubMed ID: 29072097 [TBL] [Abstract][Full Text] [Related]
14. Indole derivatives as potent inhibitors of 5-lipoxygenase: design, synthesis, biological evaluation, and molecular modeling. Zheng M; Zheng M; Ye D; Deng Y; Qiu S; Luo X; Chen K; Liu H; Jiang H Bioorg Med Chem Lett; 2007 May; 17(9):2414-20. PubMed ID: 17336065 [TBL] [Abstract][Full Text] [Related]
15. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase. Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818 [TBL] [Abstract][Full Text] [Related]
16. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. Kirrane TM; Boyer SJ; Burke J; Guo X; Snow RJ; Soleymanzadeh L; Swinamer A; Zhang Y; Madwed JB; Kashem M; Kugler S; O'Neill MM Bioorg Med Chem Lett; 2012 Jan; 22(1):738-42. PubMed ID: 22056746 [TBL] [Abstract][Full Text] [Related]
18. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors. Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368 [TBL] [Abstract][Full Text] [Related]
19. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors. Park H; Bahn YJ; Ryu SE Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739 [TBL] [Abstract][Full Text] [Related]
20. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors. Park H; Li M; Choi J; Cho H; Ham SW Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]